Galderma depositary files to register 50M depositary shares

The registrant represents that Galderma publishes information under Rule 12g3-2(b), based on the depositary’s limited investigation and reasonable good-faith belief.

Accepted by SEC EDGAR 09/18/2025 - 03:11 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

The Bank of New York Mellon, as depositary for Galderma Group AG, filed to register 50,000,000 American Depositary Shares representing the company’s common stock. The $5,000,000 proposed maximum aggregate price is an estimate used solely to calculate the registration fee; the table also lists a proposed maximum price of $0.10 per unit. The prospectus consists of the proposed American Depositary Receipt and Statement of Terms and Conditions.

Key Figures

American Depositary Shares registered: 50,000,000 American Depositary Shares Proposed maximum price per unit: $0.10 per unit Proposed maximum aggregate price: $5,000,000 +1 more

4 metrics

American Depositary Shares registered 50,000,000 American Depositary Shares Representing Galderma Group AG common stock

Proposed maximum price per unit $0.10 per unit Estimated solely for calculating the registration fee

Proposed maximum aggregate price $5,000,000 Estimated solely for calculating the registration fee

Registration fee $765.50 Amount listed in the calculation of registration fee

Key Terms

American Depositary Shares, American Depositary Receipt, Rule 12g3-2(b), Rule 457(k)

4 terms

American Depositary Shares financial

"50,000,000 American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

American Depositary Receipt financial

"Form of American Depositary Receipt and Statement of Terms and Conditions"

An American depositary receipt (ADR) is a certificate that represents shares of a foreign company traded on U.S. stock exchanges. It allows investors to buy and sell parts of a foreign company's stock easily, much like purchasing shares of a company based in their own country. ADRs make international investing more convenient and accessible for U.S. investors.

Rule 12g3-2(b) regulatory

"publishes information as contemplated under Rule 12g3-2(b)"

Rule 457(k) regulatory

"Pursuant to Rule 457(k)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many American Depositary Shares are registered for GALDY?

The amount listed for registration is 50,000,000 American Depositary Shares representing Galderma Group AG common stock; The Bank of New York Mellon is the depositary.

What does the $5 million figure mean in GALDY’s ADS registration?

The $5,000,000 proposed maximum aggregate price is an estimate used solely to calculate the registration fee under Rule 457(k), based on maximum fees or charges for issuing American Depositary Receipts evidencing American Depositary Shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

As filed with the Securities and Exchange Commission on September 18, 2025.

Registration No. 333-

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM F-6

REGISTRATION STATEMENT

under

THE SECURITIES ACT OF 1933

For Depositary Shares

Galderma Group AG

(Exact name of issuer of deposited securities as specified in its charter)

N/A

(Translation of issuer’s name into English)

Switzerland

(Jurisdiction of incorporation or organization of issuer)

THE BANK OF NEW YORK MELLON

(Exact name of depositary as specified in its charter)

240 Greenwich Street, New York, N.Y. 10286

Telephone (212) 495-1727

(Address, including zip code, and telephone number, including area code, of depositary’s principal executive offices)

The Bank of New York Mellon

Legal Department

240 Greenwich Street

New York, New York 10286

(212) 495-1784

(Address, including zip code, and telephone number, including area code, of agent for service)

Copies to:

Brian D. Obergfell, Esq.

Emmet, Marvin & Martin, LLP
120 Broadway
New York, New York 10271
(212) 238-3032

It is proposed that this filing become effective under Rule 466

☒ immediately upon filing

☐ on (Date) at (Time)

If a separate statement has been filed to register the deposited shares, check the following box. ☐

CALCULATION OF REGISTRATION FEE

Title of each class of Securities to be registered	Amount to be registered	Proposed maximum aggregate price per unit (1)	Proposed maximum aggregate offering price (1)	Amount of registration fee
American Depositary Shares representing common stock of Galderma Group AG	50,000,000 American Depositary Shares	$0.10	$5,000,000	$765.50

(1)       Estimated solely for the purpose of calculating the registration fee. Pursuant to Rule 457(k), such estimate is computed on the basis of the maximum aggregate fees or charges to be imposed in connection with the issuance of American Depositary Receipts evidencing American Depositary Shares.

The prospectus consists of the proposed Form of American Depositary Receipt and Statement of Terms and Conditions filed as Exhibit 1 to this Registration Statement, which is incorporated herein by reference.

PART I

INFORMATION REQUIRED IN PROSPECTUS

Cross Reference Sheet

	Item -1.	Description of Securities to be Registered
Item Number and Caption				Location in Form of Receipt Filed Herewith as Prospectus
1.       Name and address of depositary				Introductory Article
2.       Title of American Depositary Shares and identity of deposited securities				Face of Receipt, top center
Terms of Deposit:
(i)   The amount of deposited securities represented by each American Depositary Share				Face of Receipt, upper right corner
(ii)   The procedure for voting, if any, the deposited securities				Articles number 8 and 12
(iii)   The collection and distribution of dividends				Articles number 9 and 13
(iv)  The transmission of notices, reports and proxy soliciting material				Article number 8
(v)   The sale or exercise of rights				Articles number 4 and 9
(vi)  The deposit or sale of securities resulting from dividends, splits or plans of reorganization				Articles number 9 and 11
(vii)  Amendment, extension or termination of the deposit agreement				Article number 13 and 17
(viii)  Rights of holders of American Depositary Shares to inspect the transfer books of the depositary and the list of holders of American Depositary Shares				Article number 3
(ix)  Restrictions upon the right to deposit or withdraw the underlying securities				Articles number 2, 3, 4, 6, 11, 12 and 14
(x)   Limitation upon the liability of the depositary				Articles number 5, 8, 9, 12, 13 and 18

Item - 2.	Available Information
	As of the date of the establishment of the program for issuance of American Depositary Shares, based on the reasonable good faith belief of the Depositary, after limited investigation, the registrant represents that, as of the date hereof, the foreign issuer publishes information as contemplated under Rule 12g3-2(b) under the Securities Exchange Act of 1934, as amended		Article number 8

Part II- Information Not Required in Prospectus.

Item – 3.	Exhibits
1.	Form of American Depositary Receipt and Statement of Terms and Conditions, which contains the form of deposit agreement relating to the American Depositary Shares registered hereunder. – Filed herewith as Exhibit 1.
4.	Opinion of Emmet, Marvin & Martin, LLP, counsel for the Depositary, as to legality of the securities to be registered. – Filed herewith as Exhibit 4.

Item – 4. Undertakings

(a) The Depositary hereby undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of the American Depositary Shares, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities, and (2) made generally available to the holders of the underlying securities by the issuer.

(b) If the amounts of fees charged are not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request.  The Depositary undertakes to notify each registered holder of American Depositary Shares thirty days before any change in the fee schedule.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on September 18, 2025.

Legal entity created by the agreement for the issuance of American Depositary Shares for common stock of Galderma Group AG.

By: The Bank of New York Mellon,
As Depositary

By: /s/ Vanessa Salazar

Name: Vanessa Salazar

Title: Senior Vice President

INDEX TO EXHIBITS

Exhibit
Number Exhibit

1	Form of American Depositary Receipt and Statement of Terms and Conditions, which contains the form of deposit agreement relating to the American Depositary Shares registered hereunder.
4	Opinion of Emmet, Marvin & Martin, LLP, counsel for the Depositary, as to the legality of the securities being registered.